In order to ensure the smooth implementation of the newly revised “Provisions for Drug Registration”, National Medical Products Administration (NMPA) is currently stepping up the upgrading digital systems for drug registration. The relevant matters are now announced as follows:
1.On June 24, 2020, the NMPA government website will release a new version of the drug registration application software for applicants.
2. From June 28 to June 30, in order to carry out the new and old system switching and joint debugging test, the NMPA and the provincial (regional, municipal) drug regulatory bureaus will suspend the use of existing drug registration related systems, and the corresponding drug registration Acceptance and certification services will also be suspended. During an emergency during this period, please contact the relevant department of NPMA.
3. From July 1, 2020, NMPA will launch a new version of the drug registration related system. Drug registration applicants are reminded to download the latest version of the application software and submit registration applications as required.
For more details on how this may impact you. Please contact: info@accestra.com
